Merit Medical Systems, Inc. (MMSI)
NASDAQ: MMSI · Real-Time Price · USD
103.94
+0.67 (0.65%)
At close: Mar 28, 2025, 4:00 PM
107.22
+3.28 (3.16%)
After-hours: Mar 28, 2025, 7:49 PM EDT
Merit Medical Systems Stock Forecast
Stock Price Forecast
The 10 analysts with 12-month price forecasts for Merit Medical Systems stock have an average target of 111.7, with a low estimate of 88 and a high estimate of 127. The average target predicts an increase of 7.47% from the current stock price of 103.94.
Analyst Consensus: Strong Buy
Analyst Ratings
The average analyst rating for Merit Medical Systems stock from 10 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Oct '24 | Nov '24 | Dec '24 | Jan '25 | Feb '25 | Mar '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 5 | 5 | 6 | 6 | 6 | 6 |
| Hold | 2 | 2 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 10 | 10 | 10 | 10 | 10 | 10 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| JP Morgan | JP Morgan | Buy Initiates $120 | Buy | Initiates | $120 | +15.45% | Mar 28, 2025 |
| Barrington Research | Barrington Research | Buy Maintains $115 → $111 | Buy | Maintains | $115 → $111 | +6.79% | Feb 26, 2025 |
| Canaccord Genuity | Canaccord Genuity | Strong Buy Maintains $128 → $127 | Strong Buy | Maintains | $128 → $127 | +22.19% | Feb 26, 2025 |
| Wells Fargo | Wells Fargo | Buy Maintains $120 → $117 | Buy | Maintains | $120 → $117 | +12.56% | Feb 26, 2025 |
| Needham | Needham | Strong Buy Maintains $122 → $116 | Strong Buy | Maintains | $122 → $116 | +11.60% | Feb 26, 2025 |
Financial Forecast
Revenue This Year
1.51B
from 1.36B
Increased by 11.09%
Revenue Next Year
1.60B
from 1.51B
Increased by 6.17%
EPS This Year
3.72
from 2.03
Increased by 83.29%
EPS Next Year
4.15
from 3.72
Increased by 11.64%
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.6B | 1.7B | 1.8B | ||
| Avg | 1.5B | 1.6B | 1.7B | ||
| Low | 1.4B | 1.5B | 1.5B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 15.0% | 10.7% | 11.4% | ||
| Avg | 11.1% | 6.2% | 4.9% | ||
| Low | 5.1% | -0.4% | -3.7% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 3.89 | 4.40 | 4.70 | ||
| Avg | 3.72 | 4.15 | 4.43 | ||
| Low | 3.53 | 3.92 | 4.11 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 91.4% | 18.2% | 13.2% | ||
| Avg | 83.3% | 11.6% | 6.7% | ||
| Low | 73.8% | 5.4% | -1.1% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.